Buxo Zachary, D Cramer John
Department of Otolaryngology-Head and Neck Surgery, Wayne State University School of Medicine, Detroit, Michigan, USA.
Otolaryngol Head Neck Surg. 2025 Feb;172(2):693-696. doi: 10.1002/ohn.1058. Epub 2024 Nov 19.
The persistent challenge of high pharmaceutical prices has led to the emergence of vertically integrated direct-to-consumer distributors like Mark Cuban Cost Plus Drug Company (MCCPDC). This study aims to evaluate a cost-saving alternative method for medication sourcing. The most frequently prescribed medications by otolaryngologists were identified through analysis of Medicare Part D data, utilizing prescriber type as a filter. Medications were assessed for availability on the MCCPDC website and drug form consistency. Cost analysis was conducted comparing current pharmaceutical spending against MCCPDC pricing. Potential otolaryngology-driven savings were estimated at $55.6 million and $1 billion if in effect across all specialties. Our findings suggest considerable potential savings for Medicare by purchasing generic medications at MCCPDC prices.
药品价格居高不下这一长期挑战催生了像马克·库班成本加成药品公司（MCCPDC）这样的垂直整合型直接面向消费者的经销商。本研究旨在评估一种节省成本的药品采购替代方法。通过分析医疗保险D部分的数据，并以开处方者类型作为筛选条件，确定了耳鼻喉科医生最常开具的药物。评估了这些药物在MCCPDC网站上的可获得性以及药物剂型的一致性。进行了成本分析，将当前的药品支出与MCCPDC的定价进行比较。如果在所有专科中都有效实施，耳鼻喉科推动的潜在节省估计为5560万美元和10亿美元。我们的研究结果表明，通过以MCCPDC的价格购买通用药物，医疗保险有相当大的潜在节省空间。
